-
Sources suggested that the multiple could be as low as the 13x range as valuations reset. -
The CEO said Ascot would deploy capital where it sees opportunities.
-
The former leader, Kirby Hill, will assume the role of chairman, captives and specialty programs.
-
Strong underwriting performance and aggressive repricing of risks in most lines has aided stability.
-
The result has been a sharp increase in the use of captives.
-
They cover environment, political violence, equipment and cannabis.
-
The medical CPI is up 3.1% for the last 12 months.
-
“Models aren't going to tell you what the emergent risks today are,” Dolan said.
-
The company completed its upsized IPO last week and traded up to 1.3x book.
-
The suit names former Marsh execs Hanrahan and Andrews as defendants.
-
Growth and returns on equity fall, but most of the industry is still profitable.
-
The company’s upsized public offering priced at $30 per ordinary share.
